Element Apothec founder Dr. Swathi Varanasi PharmD is a Pharmacist | Entrepreneur, Researcher, Author, and podcaster talking about the evolution and opportunities for pharmacists as content developers. Our next guest is Keira Smith the Associate Editor at i3 Health, developers of mobile continuing education for Pharmacists and Physicians.

In this conversation, we discuss the things you should be considering when making the decision about which programs to rank for the match

WARNING: There is talk of tragedy and death from drug over dose in this episode that might be distressing for some people to hear This is a quick unedited episode I decided to do that shows how a pharmacist sees the opioid crisis and Fentanyl overdoses. I know this is our of the normal that we usually do here but this was very near and dear to my heart and thought it was important to get the information out there. Reach out to me @doctormixalot for any questions and I was serious about the call to action at the end of this episode. Thank you for listening. Much Love, Dr. H

I’m so excited to share this next episode with you where I got the opportunity to interview one of my students from the Build Your Holistic Herbal Practice Mentorship. Linda’s personality really comes through and the level of passion she has for supporting her clients - because she is walking the path alongside them.

Linda Valazza is a seasoned NASM Certified Nutrition & Lifestyle Coach with over 28 years of experience in creating individual fitness and nutrition programs uniquely designed to meet clients' personal needs and health/wellness goals.

She is leveraging her experience as a Pharmacist to help chronic disease patients by reviewing medications and recommending supplements, as well as helping them make dietary and exercise changes to obtain better health. She continually exceeds expectations by creating valuable partnerships and works well with people at all levels of the organization, including stakeholders, customers, vendors, and team members.

Linda is also the mother of 4 kids, married to Steve for 30 years, and has completed 2 full marathons after Autoimmune disease diagnosis.

Connect with Linda:

https://www.exerciseprescriptionlv.com https://www.facebook.com/exerciseprescriptionlv https://www.instagram.com/theexerciseprescriptionlv/

Free gift: "Six ways to obliterate the limits of AutoImmune Disease"

*Special introductory price on my new Autoimmune disease starter program for listeners of the podcast - contact Linda via [email protected]*

Introducing the Neural Pharm Podcast, featuring your hosts Colby Burns, PharmD, and Christopher Toney, PharmD. Episode 1 establishes the mission of the podcast, and covers the groundbreaking MAPP1 and MAPP2 trials that established MDMA as a breakthrough therapy for PTSD. We also cover key safety data including drug interactions, pharmacokinetics (or metabolism), and pharmacogenomics (or gene-drug interactions). Come join us!

***Correction Alert: The Ted talk referenced by Colby in the conclusion of the podcast was given by Dr. Ben Sessa, not Sassa (see the attached video in the reference section)****

References:

Mitchell J, et al. MDMA Assisted Therapy for Severe PTSD: A randomized, double blind, placebo controlled phase 3 study. Nature. 10 May 2021 <https://www.nature.com/articles/s41591-021-01336-3>

Mental Health By the Numbers. National Alliance on Mental Illness. 2023.

Sessa B, et al. A Review of 3,4-methylenedioxymethamphetamine (MDMA) Assisted Psychotherapy. 2019(10).

Sessa B. Is MDMA psychiatry’s antibiotic? Tedx University of Bristol. 5 July 2016.

Silverstone P. The Promise of Psychedelics: Science Based Hope for Better Mental Health. 2022 Apr 21. Ingenium books. 

www.thesexualhealthpharmacist.com

www.instagram.com/thesexualhealthpharmacist

www.revcustomrx.com

THUG DRUGS! With a name like that, it has to be good! Even better than Smuckers (Age old ad slogan for jelly/jam)!

From OTC and prescription opioids to controlled substance opioids, Heroin to Oxy, the PAIN GUY on the PAIN POD will discuss legal and illicit opioids in the realms of pain management, substance use disorder (addiction), and our communities, and globe for that matter.

Get ready for some homework, as you’ll definitely end up watching American Pain, Dopesick, Drugs Inc., Hamilton’s Pharmacopeia, and maybe even Lord of the Rings, wait, Lord of the Rings, yup, addiction, the entire time.

Come one, come all, to the Pain Pod!!!

Drug/Overdose Trends

• https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates

• https://www.iqvia.com/insights/the-iqvia-institute/reports/prescription-opioid-trends-in-the-united-states

Illicit Substances Resources

• Erowid

• DEA Reports

o Drugs of Abuse

o National Drug Threat Assessment

• INCB (International Narcotics Control Board)

• UNODC (United Nations Office on Drugs and Crime)

• European Monitoring Centre for Drugs and Drug Addiction

• CESAR (Center for Substance Abuse Research)

• NIDA (National Institute on Drug Abuse)

• Online Blogs o Blue Light o Drug Forum

Educational Objectives

• Outline the place in therapy for targeted therapies based on patient-specific factors and subtype of early-stage breast cancer

Faculty:

Allison R. Butts, PharmD, BCOP

Pharmacist Manager, Oncology

Breast Oncology Clinical Pharmacy Specialist

Acute Care Pharmacy Services

UK HealthCare- Markey Cancer

Lexington, Kentucky

Director, PGY2 Oncology Residency Program

UK HealthCare

Lexington, Kentucky

Allison R. Butts, PharmD, BCOP, has the following financial relationships with commercial interests to disclose:

Consultant: AstraZeneca; BeyondSpring (one-time advisory boards)

Moderator:

Laura R. Bobolts, PharmD, BCOP

SVP, Clinical Strategy and Growth

OncoHealth

Laura R. Bobolts, PharmD, BCOP, has no financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-239-H01-P. The activity is available for CE credit through May 31, 2024.

This activity is supported by independent medical educational grants from AstraZeneca; Merck & Co., Inc.; Puma Biotechnology Inc., and Lilly.